Cowen Downgrades Complete Genomic (GNOM) to Neutral
Tweet
Share
E-mailGet Alerts GNOM Hot Sheet
Price: $55.10 -1.59%
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 18 | New: 23
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 18 | New: 23
Join SI Premium – FREE
Cowen downgraded Complete Genomic (NASDAQ: GNOM) from Outperform to Neutral.
For more ratings news on Complete Genomic click here and for the rating history of Complete Genomic click here.
Shares of Complete Genomic closed at $17.11 yesterday.
For more ratings news on Complete Genomic click here and for the rating history of Complete Genomic click here.
Shares of Complete Genomic closed at $17.11 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist Securities Downgrades Lululemon (LULU) to Sell, 'we believe there are numerous issues at hand'
- Citi Downgrades Svenska Handelsbanken AB (SHBA:SS) (SVNLY) to Sell
- AerCap Holdings (AER) PT Raised to $180 at TD Cowen
Create E-mail Alert Related Categories
DowngradesRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
